human alpha1-proteinase inhibitor

Italy

Drugs containing this active substance

  • PLITALFA

    It is used for chronic therapy in individuals with a hereditary alpha-1 antitrypsin deficiency. It serves to restore balance in the lungs and to prevent the worsening of pulmonary emphysema.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    human alpha1-proteinase inhibitor -

    ATC: B02AB02

    Manufacturer: GRIFOLS ITALIA S.P.A.

  • It is used for chronic therapy in subjects with alpha-1 antitrypsin deficiency. It serves to restore balance in the lungs and to prevent the worsening of pulmonary emphysema.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    human alpha1-proteinase inhibitor -

    ATC: B02AB02

    Manufacturer: INSTITUTO GRIFOLS S.A.

  • It is used in adults suffering from a severe alpha-proteinase inhibitor deficiency (a hereditary disease also known as alpha-1 antitrypsin deficiency) who have developed pulmonary emphysema.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    human alpha1-proteinase inhibitor -

    ATC: B02AB02

    Manufacturer: CSL BEHRING GMBH